Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minireview: nucleotide prodrugs

R J Jones1, N Bischofberger

  • 1Gilead Sciences, Foster City, CA 94404, USA.

Antiviral Research
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Nucleotide prodrugs enhance drug delivery and therapeutic potential by overcoming limitations of charged nucleotides. These prodrugs improve oral absorption, intracellular delivery, and tissue-specific targeting, leading to reduced toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Purinoceptors in the Central Nervous System.

Drug development research·2024
Same author

Cancer Trial Impact: Understanding Implementation of the Short Course Oncology Treatment (SCOT) Trial Findings in colorectal cancer at a National Level.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Using diffusion MRI data acquired with ultra-high gradient strength to improve tractography in routine-quality data.

NeuroImage·2021
Same author

Fermentative volatile fatty acid production and recovery from grass using a novel combination of solids separation, pervaporation, and electrodialysis technologies.

Bioresource technology·2021
Same author

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same journal

Nanoparticles in viral pneumonia: diagnosis, therapy, and prevention.

Antiviral research·2026
Same journal

The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata.

Antiviral research·2026
Same journal

Ginsenoside Rb2-based inactivation enables a Zika vaccine that maintains pregnancy and protects offspring against virus.

Antiviral research·2026
Same journal

ITGA4 drives pathogenesis of flavivirus and inhibition of it protects mice against Japanese encephalitis virus infection.

Antiviral research·2026
Same journal

Corrigendum to "A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2" [Antivir. Res. 225 (2024) 105854].

Antiviral research·2026
Same journal

Effects of RNA polymerase inhibitors on nucleotidylylation of human norovirus VPg.

Antiviral research·2026
See all related articles

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Nucleotides exhibit diverse biological activities, showing promise as drug candidates for various diseases.
  • The inherent negative charge of nucleotides poses challenges for drug delivery, including poor absorption and distribution.
  • Nucleotide prodrugs offer a strategy to overcome these limitations and improve therapeutic efficacy.

Purpose of the Study:

  • To explore the advantages and applications of nucleotide prodrugs in drug development.
  • To investigate how prodrug strategies can enhance the delivery and activity of nucleotides.
  • To highlight the importance of considering in vivo factors in prodrug design and evaluation.

Main Methods:

  • Utilizing intracellular triggers (reducing potential, enzyme activity, pH) for enhanced intracellular delivery.

Related Experiment Videos

  • Designing prodrugs for tissue-specific delivery in vivo.
  • Incorporating adequate assays and design criteria for prodrug development.

    • Main Results:

    • Nucleotide prodrugs successfully increased oral absorption of nucleotides in vivo.
    • Intracellular delivery via prodrugs led to enhanced potency and selectivity.
    • Tissue-specific delivery resulted in altered selectivity and reduced toxicity.

    Conclusions:

    • Nucleotide prodrugs are effective in overcoming the limitations of parent nucleotides, improving drug delivery and therapeutic outcomes.
    • Prodrug design must consider in vivo complexities like metabolism and distribution for accurate prediction of efficacy.
    • Further research into nucleotide prodrugs holds significant potential for developing novel therapeutics.